Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 4 , Pages 684-690 , April 2008

Activation of Platelet-Rich Plasma Using Soluble Type I Collagen

  • Duretti Fufa, MD

      Affiliations

    • Resident, Department of Orthopaedic Surgery, Harvard Medical School, Children’s Hospital of Boston, Boston, MA.
    • ,
  • Blake Shealy

      Affiliations

    • Undergraduate Student, Department of Orthopaedic Surgery, Harvard Medical School, Children’s Hospital of Boston, Boston, MA.
    • ,
  • May Jacobson, PhD

      Affiliations

    • Research Associate in Medicine, CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA.
    • ,
  • Sherwin Kevy, MD

      Affiliations

    • Associate Professor of Pediatrics, CBR Institute for Biomedical Research, Harvard Medical School, Boston, MA.
    • ,
  • Martha M. Murray, MD

      Affiliations

    • Assistant Professor, Department of Orthopaedic Surgery, Harvard Medical School, Children’s Hospital of Boston, Boston, MA.
    • Corresponding Author InformationAddress correspondence and reprint requests to Dr Murray: Department of Orthopedic Surgery, Children’s Hospital of Boston, 300 Longwood Avenue, Boston, MA 02115

References 

  1. Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg. 1997;55:1294
  2. Marx RE, Carlson ER, Eichstaedt RM, et al. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod. 1998;85:638
  3. Sclafani AP, Romo T, Ukrainsky G, et al. Modulation of wound response and soft tissue ingrowth in synthetic and allogeneic implants with platelet concentrate. Arch Facial Plast Surg. 2005;7:163
  4. Babbush CA, Kevy SV, Jacobson MS. An in vitro and in vivo evaluation of autologous platelet concentrate in oral reconstruction. Implant Dent. 2003;12:24
  5. Murray MM, Spindler KP, Devin C, et al. Use of a collagen-platelet rich plasma scaffold to stimulate healing of a central defect in the canine ACL. J Orthop Res. 2006;24:820
  6. Murray MM, Spindler KP, Abreu E, et al. Collagen–platelet-rich plasma hydrogel enhances primary repair of the porcine anterior cruciate ligament. J Orthop Res. 2007;25:81
  7. Okuda K, Kawase T, Momose M, et al. Platelet-rich plasma contains high levels of platelet-derived growth factor and transforming growth factor-beta and modulates the proliferation of periodontally related cells in vitro. J Periodontol. 2003;74:849
  8. Weibrich G, Kleis WK, Hafner G. Growth factor levels in the platelet-rich plasma produced by 2 different methods: Curasan-type PRP kit versus PCCS PRP system. Int J Oral Maxillofac Implants. 2002;17:184
  9. Eppley BL, Woodell JE, Higgins J. Platelet quantification and growth factor analysis from platelet-rich plasma: Implications for wound healing. Plast Reconstr Surg. 2004;114:1502
  10. Weibrich G, Kleis WK. Curasan PRP kit vs PCCS PRP system: Collection efficiency and platelet counts of two different methods for the preparation of platelet-rich plasma. Clin Oral Implants Res. 2002;13:437
  11. Dennison DK, Vallone DR, Pinero GJ, et al. Differential effect of TGF-beta 1 and PDGF on proliferation of periodontal ligament cells and gingival fibroblasts. J Periodontol. 1994;65:641
  12. Kawase T, Okuda K, Wolff LF, et al. Platelet-rich plasma–derived fibrin clot formation stimulates collagen synthesis in periodontal ligament and osteoblastic cells in vitro. J Periodontol. 2003;74:858
  13. MacNeil RL, D’Errico J, Strayhorn C, et al. Agents with periodontal regenerative potential regulate cell-mediated collagen lattice contraction in vitro. J Dent Res. 1996;75:903
  14. Matsuda N, Lin WL, Kumar NM, et al. Mitogenic, chemotactic, and synthetic responses of rat periodontal ligament fibroblastic cells to polypeptide growth factors in vitro. J Periodontol. 1992;63:515
  15. Park JS, Kim JY, Cho JY, et al. Epidermal growth factor (EGF) antagonizes transforming growth factor (TGF)-beta1–induced collagen lattice contraction by human skin fibroblasts. Biol Pharm Bull. 2000;23:1517
  16. Frechette JP, Martineau I, Gagnon G. Platelet-rich plasmas: Growth factor content and roles in wound healing. J Dent Res. 2005;84:434
  17. Lawson JH. The clinical use and immunologic impact of thrombin in surgery. Semin Thromb Hemost. 2006;32(Suppl 1):98
  18. Murray MM, Forsythe B, Chen F, et al. The effect of thrombin on ACL fibroblast interactions with collagen hydrogels. J Orthop Res. 2006;24:508
  19. Landesberg R, Roy M, Glickman RS. Quantification of growth factor levels using a simplified method of platelet-rich plasma gel preparation. J Oral Maxillofac Surg. 2000;58:297
  20. Landesberg R, Burke A, Pinsky D, et al. Activation of platelet-rich plasma using thrombin receptor agonist peptide. J Oral Maxillofac Surg. 2005;63:529
  21. Lee J, Harwood FL, Akeson WH, et al. Growth factor expression in healing rabbit medial collateral and anterior cruciate ligaments. Iowa Orthop J. 1998;18:19
  22. Lynch SE, Nixon JC, Colvin RB, et al. Role of platelet-derived growth factor in wound healing: Synergistic effects with other growth factors. Proc Natl Acad Sci U S A. 1987;84:7696
  23. Wang XL, Liu SX, Wilcken DE. Circulating transforming growth factor beta 1 and coronary artery disease. Cardiovasc Res. 1997;34:404
  24. Clausen T, Djurovic S, Reseland JE, et al. Altered plasma concentrations of leptin, transforming growth factor-beta(1) and plasminogen activator inhibitor type 2 at 18 weeks of gestation in women destined to develop pre-eclampsia: Circulating markers of disturbed placentation?. Placenta. 2002;23:380
  25. Dziadzio M, Smith RE, Abraham DJ, et al. Circulating levels of active transforming growth factor beta1 are reduced in diffuse cutaneous systemic sclerosis and correlate inversely with the modified Rodnan skin score. Rheumatology (Oxford). 2005;44:1518
  26. Sanderson N, Factor V, Nagy P, et al. Hepatic expression of mature transforming growth factor beta 1 in transgenic mice results in multiple tissue lesions. Proc Natl Acad Sci U S A. 1995;92:2572
  27. Shah M, Revis D, Herrick S, et al. Role of elevated plasma transforming growth factor-beta1 levels in wound healing. Am J Pathol. 1999;154:1115
  28. Scharstuhl A, Vitters EL, van der Kraan PM, et al. Reduction of osteophyte formation and synovial thickening by adenoviral overexpression of transforming growth factor beta/bone morphogenetic protein inhibitors during experimental osteoarthritis. Arthritis Rheum. 2003;48:3442
  29. Hsu C, Chang J. Clinical implications of growth factors in flexor tendon wound healing. J Hand Surg [Am]. 2004;29:551
  30. Le AD, Zhang Q, Wu Y, et al. Elevated vascular endothelial growth factor in keloids: Relevance to tissue fibrosis. Cells Tissues Organs. 2004;176:87
  31. Ohtani K, Egashira K, Hiasa K, et al. Blockade of vascular endothelial growth factor suppresses experimental restenosis after intraluminal injury by inhibiting recruitment of monocyte lineage cells. Circulation. 2004;110:2444
  32. Herve MA, Buteau-Lozano H, Mourah S, et al. VEGF189 stimulates endothelial cell proliferation and migration in vitro and up-regulates the expression of Flk-1/KDR mRNA. Exp Cell Res. 2005;309:24
  33. Lee SS, Joo YS, Kim WU, et al. Vascular endothelial growth factor levels in the serum and synovial fluid of patients with rheumatoid arthritis. Clin Exp Rheumatol. 2001;19:321
  34. Nielsen HJ, Werther K, Mynster T, et al. Soluble vascular endothelial growth factor in various blood transfusion components. Transfusion. 1999;39:1078
  35. Cho ML, Jung YO, Moon YM, et al. Interleukin-18 induces the production of vascular endothelial growth factor (VEGF) in rheumatoid arthritis synovial fibroblasts via AP-1–dependent pathways. Immunol Lett. 2006;103:159
  36. Wagner S, Coerper S, Fricke J, et al. Comparison of inflammatory and systemic sources of growth factors in acute and chronic human wounds. Wound Repair Regen. 2003;11:253
  37. Murray MM, Spindler KP, Ballard P, et al. Enhanced histologic repair in a central defect in the anterior cruciate ligament with a collagen-PRP scaffold. J Orthop Res. 2007;25:1007

 Supported by the CIMIT through US Department of Defense funding under cooperative agreement DAMD17-02-2-0006 and National Institutes of Health (NIH) grant R01AR054099. Salary support was provided by NIH grant K02 AR049346 (to MM). Support was also provided by the Center for Blood Research, Boston, MA.

PII: S0278-2391(07)01487-5

doi: 10.1016/j.joms.2007.06.635

Journal of Oral and Maxillofacial Surgery
Volume 66, Issue 4 , Pages 684-690 , April 2008

Article Tools

* Image Usage & Resolution